A Digital Cure for High Drug Prices?Apr 26, 2017
More digitalization in drug development could help biopharmaceuticals improve R&D and counter pricing pressure—but disruption also brings threats.
Squeezing more life out of products and raw materials could be the next disruptive trend in the global markets.
What to do with an effective long-term investment strategy, in a market with attention-deficit syndrome?
Sign up to get Morgan Stanley Ideas delivered to your inbox.
Thank You for Subscribing!
Would you like to help us improve our coverage of topics that might interest you? Tell us about yourself.
Two years after winning the Kellogg-Morgan Stanley Sustainable Investing Challenge, Blue Forest Conservation is preparing to pilot a financing vehicle to fund forest restoration in California.
Morgan Stanley helped the Whitney raise capital to build its new home in Manhattan’s Meatpacking district, where new generations of visitors can experience American art.
The rosy outlook for U.S. equities could soon fade, says Cross-Asset Strategist Andrew Sheets, and Europe may provide an unexpected counterpoint.
Even after a strong few quarters, the runway for value stocks is still many months long, says Chief European Equity Strategist Graham Secker. What’s the key to their performance?
Ellen Zentner, Chief US Economist, on the Fed and Trump's expected fiscal policies.
Bonds are still an important component of portfolio diversification, but it’s now crucial for investors to get the right mix of credit and maturities, says Jim Caron, Fixed Income Portfolio Manager
Smartphones made digital more personal, but the next phase of digitalization will focus on improving corporate efficiency and productivity, says Francois Meunier.
The pace at which nascent tech companies are maturing has never been faster, says Internet Analyst Andrea Ferraz. What’s the key to their growth and scale?